Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine (Q43873037)
scientific article published in February 2002
Language:
(P31) (Q13442814)
(P304) 143-149
(P407) (Q1860)
(P433) 2
(P478) 8
(P577) Friday, February 1, 2002
(P921) (Q190564)
(P1433) (Q1633234)
(P1476) "Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine" (language: en)
(P2093) Marcela V Karpuj
Mark W Becher
Joe E Springer
Dorothee Chabas
Sawsan Youssef
Rosetta Pedotti
Dennis Mitchell
Lawrence Steinman
(P2860) (Q72233686)
(Q36250381)
(Q77525872)
(Q33546888)
(Q27860836)
(Q45296134)
(Q36395820)
(Q48537185)
(Q40082696)
(Q39246771)
(Q29615357)
(Q28114818)
(Q28246858)
(Q29617982)
(Q45296163)
(Q45298596)
(Q48574817)
(Q48373564)
(Q28588314)
(Q33897927)
(Q77430975)
(Q72921922)
(Q68236971)
(Q48357496)
(Q45298039)
(Q48243137)
(Q27733391)
(Q47982815)
(Q46308714)
(Q45300376)
(Q35079106)
(Q41724127)
(Q27622332)
(Q73561135)
(Q47991885)
(Q28207482)
(Q45300532)
(Q56772848)
(Q45300872)
(Q43820046)
(Q78060140)
(Q52532018)
other details
description scientific article published in February 2002

External Links